USPTO trademark

NEOMAB-CLC

RegisteredUSPTOWord markClass 31Class 42

"NEOMAB-CLC" is a word mark owned by GemPharmatech Co., Ltd., filed at the USPTO on May 22, 2024. It is registered and covers classes 31 and 42.

View GemPharmatech Co., Ltd. portfolioGet this data via the API
Official USPTO record
NEOMAB-CLC trademark as filed
As filed with the USPTO
Status
Registered
Since September 2, 2025
Filed
May 22, 2024
Registered
September 2, 2025
Expires
Not recorded
Application no.
98563302
Registration no.
7932491
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns NEOMAB-CLC

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GemPharmatech Co., Ltd.

Nanjing Jiangsu, China

31 trademarks in the portfolioView company

Representative

Tim O'Keeffe

Bayramoglu Law Offices LLC

Goods and services

What the mark covers

The products and services NEOMAB-CLC is filed for, grouped by Nice class.

  • Algae, unprocessed, for human or animal consumption; Animal foodstuffs; Bran mash for animal consumption; Edible chews for animals; Flaxseed meal for animal consumption; Fruit, fresh; Garden herbs, fresh; Litter for animals; Live animals; Spawn for agricultural purposes

  • Biological research; Chemical research; Conducting of feasibility studies in the field of new technologies; Culturing of cells for others for scientific research purposes; Medical research; Research and development of new products for others; Scientific laboratory services; Scientific research; Scientific research in the field of genetics; Technical research in the field of pharmaceutical studies

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Case assigned to intent to use paralegal
  7. Use amendment filed
  8. Teas statement of use received
  9. Noa e-mailed - sou required from applicant
  10. Official gazette publication confirmation e-mailed

6 earlier steps on the official record.

FAQ

About NEOMAB-CLC

Who owns the trademark "NEOMAB-CLC"?

The USPTO trademark "NEOMAB-CLC" (application 98563302) is owned by GemPharmatech Co., Ltd.

What is the status of "NEOMAB-CLC"?

Its status at the USPTO is: registered.

When was "NEOMAB-CLC" registered?

It was registered on September 2, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NEOMAB-CLC and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2926-10f8-7462-ae3a-f87a08ad8cfe
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2926-10f8-7462-ae3a-f87a08ad8cfe",
  "object": "trademark",
  "mark_text": "NEOMAB-CLC",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98563302",
  "filing_date": "2024-05-22",
  "nice_classes": [
    31,
    42
  ],
  "owners": [
    {
      "name": "GemPharmatech Co., Ltd.",
      "entity_id": "ent_019eb7dd-5b13-70cd-880d-9b7bc5be78fb"
    }
  ]
}